253 related articles for article (PubMed ID: 25848016)
41. Angelman syndrome - insights into a rare neurogenetic disorder.
Buiting K; Williams C; Horsthemke B
Nat Rev Neurol; 2016 Oct; 12(10):584-93. PubMed ID: 27615419
[TBL] [Abstract][Full Text] [Related]
42. Impairment of TrkB-PSD-95 signaling in Angelman syndrome.
Cao C; Rioult-Pedotti MS; Migani P; Yu CJ; Tiwari R; Parang K; Spaller MR; Goebel DJ; Marshall J
PLoS Biol; 2013; 11(2):e1001478. PubMed ID: 23424281
[TBL] [Abstract][Full Text] [Related]
43. Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model.
Silva-Santos S; van Woerden GM; Bruinsma CF; Mientjes E; Jolfaei MA; Distel B; Kushner SA; Elgersma Y
J Clin Invest; 2015 May; 125(5):2069-76. PubMed ID: 25866966
[TBL] [Abstract][Full Text] [Related]
44. Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome.
Lee D; Chen W; Kaku HN; Zhuo X; Chao ES; Soriano A; Kuncheria A; Flores S; Kim JH; Rivera A; Rigo F; Jafar-Nejad P; Beaudet AL; Caudill MS; Xue M
Elife; 2023 Jan; 12():. PubMed ID: 36594817
[No Abstract] [Full Text] [Related]
45. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome.
DeLorey TM; Handforth A; Anagnostaras SG; Homanics GE; Minassian BA; Asatourian A; Fanselow MS; Delgado-Escueta A; Ellison GD; Olsen RW
J Neurosci; 1998 Oct; 18(20):8505-14. PubMed ID: 9763493
[TBL] [Abstract][Full Text] [Related]
46. Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease.
Maheshwari M; Samanta A; Godavarthi SK; Mukherjee R; Jana NR
J Biol Chem; 2012 Aug; 287(35):29949-57. PubMed ID: 22787151
[TBL] [Abstract][Full Text] [Related]
47. Genotype-Phenotype Correlations in Angelman Syndrome.
Yang L; Shu X; Mao S; Wang Y; Du X; Zou C
Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34203304
[TBL] [Abstract][Full Text] [Related]
48. Impaired hippocampal plasticity and altered neurogenesis in adult Ube3a maternal deficient mouse model for Angelman syndrome.
Mardirossian S; Rampon C; Salvert D; Fort P; Sarda N
Exp Neurol; 2009 Dec; 220(2):341-8. PubMed ID: 19782683
[TBL] [Abstract][Full Text] [Related]
49. Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome.
Riday TT; Dankoski EC; Krouse MC; Fish EW; Walsh PL; Han JE; Hodge CW; Wightman RM; Philpot BD; Malanga CJ
J Clin Invest; 2012 Dec; 122(12):4544-54. PubMed ID: 23143301
[TBL] [Abstract][Full Text] [Related]
50. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice.
Miura K; Kishino T; Li E; Webber H; Dikkes P; Holmes GL; Wagstaff J
Neurobiol Dis; 2002 Mar; 9(2):149-59. PubMed ID: 11895368
[TBL] [Abstract][Full Text] [Related]
51. Effects of the synthetic neurosteroid ganaxolone on seizure activity and behavioral deficits in an Angelman syndrome mouse model.
Ciarlone SL; Wang X; Rogawski MA; Weeber EJ
Neuropharmacology; 2017 Apr; 116():142-150. PubMed ID: 27986596
[TBL] [Abstract][Full Text] [Related]
52. Region-specific impairments in striatal synaptic transmission and impaired instrumental learning in a mouse model of Angelman syndrome.
Hayrapetyan V; Castro S; Sukharnikova T; Yu C; Cao X; Jiang YH; Yin HH
Eur J Neurosci; 2014 Mar; 39(6):1018-1025. PubMed ID: 24329862
[TBL] [Abstract][Full Text] [Related]
53. Generation and Characterization of a Novel Angelman Syndrome Mouse Model with a Full Deletion of the
Syding LA; Kubik-Zahorodna A; Nickl P; Novosadova V; Kopkanova J; Kasparek P; Prochazka J; Sedlacek R
Cells; 2022 Sep; 11(18):. PubMed ID: 36139390
[TBL] [Abstract][Full Text] [Related]
54. Replicable in vivo physiological and behavioral phenotypes of the
Dhamne SC; Silverman JL; Super CE; Lammers SHT; Hameed MQ; Modi ME; Copping NA; Pride MC; Smith DG; Rotenberg A; Crawley JN; Sahin M
Mol Autism; 2017; 8():26. PubMed ID: 28638591
[TBL] [Abstract][Full Text] [Related]
55. Sex-Dependent Sensory Phenotypes and Related Transcriptomic Expression Profiles Are Differentially Affected by Angelman Syndrome.
Koyavski L; Panov J; Simchi L; Rayi PR; Sharvit L; Feuermann Y; Kaphzan H
Mol Neurobiol; 2019 Sep; 56(9):5998-6016. PubMed ID: 30706369
[TBL] [Abstract][Full Text] [Related]
56. Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3a
Moreira-de-Sá A; Gonçalves FQ; Lopes JP; Silva HB; Tomé ÂR; Cunha RA; Canas PM
Mol Neurobiol; 2021 Jun; 58(6):2543-2557. PubMed ID: 33464534
[TBL] [Abstract][Full Text] [Related]
57. Ketone ester supplementation attenuates seizure activity, and improves behavior and hippocampal synaptic plasticity in an Angelman syndrome mouse model.
Ciarlone SL; Grieco JC; D'Agostino DP; Weeber EJ
Neurobiol Dis; 2016 Dec; 96():38-46. PubMed ID: 27546058
[TBL] [Abstract][Full Text] [Related]
58. Characterizing spine issues: If offers novel therapeutics to Angelman syndrome.
Yang X
Dev Neurobiol; 2020 May; 80(5-6):200-209. PubMed ID: 32378784
[TBL] [Abstract][Full Text] [Related]
59. CIM6P/IGF-2 Receptor Ligands Reverse Deficits in Angelman Syndrome Model Mice.
Cruz E; Descalzi G; Steinmetz A; Scharfman HE; Katzman A; Alberini CM
Autism Res; 2021 Jan; 14(1):29-45. PubMed ID: 33108069
[TBL] [Abstract][Full Text] [Related]
60. Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2-q13.3 duplication syndrome.
Copping NA; Christian SGB; Ritter DJ; Islam MS; Buscher N; Zolkowska D; Pride MC; Berg EL; LaSalle JM; Ellegood J; Lerch JP; Reiter LT; Silverman JL; Dindot SV
Hum Mol Genet; 2017 Oct; 26(20):3995-4010. PubMed ID: 29016856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
